Showing results (281-290 of 566) with videos related to
Sort By:
Pageof 57
Arthritis Care & Research|November 23, 2020
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled TrialsTore K Kvien, Philip G Conaghan, Laure Gossec, et al.Expert Review of Molecular Diagnostics|December 23, 2021
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritisVibeke Strand, Stanley B Cohen, Jeffrey R Curtis, et al.BMC Rheumatology|September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week resultsAtul A Deodhar, Philip J Mease, Proton Rahman, et al.The Journal of Rheumatology|March 16, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.The Journal of Rheumatology|February 3, 2011
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritisMark C Genovese, Stanley B Cohen, David Wofsy, et al.Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.The Journal of Rheumatology|September 10, 2009
Measuring worker productivity: frameworks and measuresDorcas Beaton, Claire Bombardier, Reuben Escorpizo, et al.The Journal of Rheumatology. Supplement|June 2, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.Arthritis and Rheumatism|September 29, 2011
Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritisThomas Karonitsch, Karolina von Dalwigk, Carl W Steiner, et al.Pageof 57